Immune system: a double-edged sword in cancer (Q38122647)

29 August 2017

title

Immune system: a double-edged sword in cancer (English)

1 reference

29 August 2017

author name string

Bodduluru Lakshmi Narendra

1

1 reference

29 August 2017

Kasala Eshvendar Reddy

2

1 reference

29 August 2017

Saladi Shantikumar

3

1 reference

29 August 2017

Sistla Ramakrishna

4

1 reference

29 August 2017

publication date

19 July 2013

1 reference

29 August 2017

published in

Inflammation Research

1 reference

29 August 2017

volume

62

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

823-834

1 reference

Natural innate and adaptive immunity to cancer

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumor microenvironments, the immune system and cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Immune surveillance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

2011: the immune hallmarks of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Transformation of the microvascular system during multistage tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Role of TGF-beta in immune-evasion of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumor-induced death of immune cells: its mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Spontaneous and induced primary oncogenesis in natural killer (NK)-cell-deficient beige mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Role of macrophages in tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Alternatively activated macrophages in infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumor versus tumor-associated macrophages: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Plasticity of CD4+ T cell lineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Epigenetic control of T-helper-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

An update on human Th1 and Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

T cell-dependent B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Th17 cells in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Late developmental plasticity in the T helper 17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Human RORγt+ TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Naturally occurring regulatory T cells: recent insights in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

What are regulatory T cells (Treg) regulating in cancer and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

FOXP3 expression and overall survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-013-0645-9

Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers

21 January 2018

1 reference

12 December 2020

Augmentation of metastasis formation by thioglycollate-elicited macrophages

1 reference

12 December 2020

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

1 reference

12 December 2020

Tumors and the danger model.

1 reference

12 December 2020

Indoleamine 2,3-dioxygenase in tumor induced tolerance

1 reference

12 December 2020

Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy.

1 reference

12 December 2020

Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.

1 reference

12 December 2020

MHC class I down-regulation: tumour escape from immune surveillance? (review).

1 reference

12 December 2020

Tumor-associated macrophages: effectors of angiogenesis and tumor progression.

1 reference

12 December 2020

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression

1 reference

12 December 2020

Breast cancer and the immune system

1 reference

12 December 2020

High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients

1 reference

12 December 2020

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

12 December 2020

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape

1 reference

12 December 2020

Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4

1 reference

12 December 2020

Natural killer cells: role in local tumor growth and metastasis

1 reference

12 December 2020

Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors

1 reference

12 December 2020

Functions of T-cell subsets and cytokines in mycobacterial infections.

1 reference

12 December 2020

Macrophages in tumor microenvironments and the progression of tumors

1 reference

12 December 2020

A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment

1 reference

12 December 2020

10.1007/S00011-013-0645-9

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1050107382

0 references

1 reference